Covered recipient · General Payments record
LAURIE T LEE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health
General Payments · PY2021–2024
$4,406.16
- Reported across 236 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $330.26 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $93.61 | 5 |
| GENZYME CORPORATION | $67.03 | 3 |
| Amgen Inc. | $38.24 | 2 |
| Insmed, Inc. | $30.04 | 2 |
| ABBVIE INC. | $22.29 | 1 |
| IRONSHORE PHARMACEUTICALS INC. | $21.65 | 1 |
| Acerta Pharma LLC | $19.55 | 1 |
| Grifols USA, LLC | $19.29 | 1 |
| DEXCOM, INC. | $18.56 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.29 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107522822 | CMS |
| Amgen Inc. | $24.29 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117307546 | CMS |
| Amgen Inc. | $13.95 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117307548 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.55 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105505018 | CMS |
| Dexcom, Inc. | $18.56 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153374037 | CMS |
| GENZYME CORPORATION | $20.50 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139851142 | CMS |
| GENZYME CORPORATION | $23.59 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139851178 | CMS |
| GENZYME CORPORATION | $22.94 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139851180 | CMS |
| GlaxoSmithKline, LLC. | $20.47 | 01/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116499291 | CMS |
| GlaxoSmithKline, LLC. | $20.55 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116408029 | CMS |
| GlaxoSmithKline, LLC. | $20.13 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116618973 | CMS |
| GlaxoSmithKline, LLC. | $16.50 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116718035 | CMS |
| GlaxoSmithKline, LLC. | $15.96 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115752561 | CMS |
| Grifols USA, LLC | $19.29 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124736482 | CMS |
| Insmed, Inc. | $13.23 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089572934 | CMS |
| Insmed, Inc. | $16.81 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089561594 | CMS |
| IRONSHORE PHARMACEUTICALS INC. | $21.65 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146304751 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.